Research of SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has been a significant focus of scientific investigation in our company. Our scientists have been studying various aspects of the virus, including its origin, transmission, pathogenesis, diagnostics, and therapeutics.
Research has been conducted to explore potential treatments for COVID-19. We developed SARS-CoV-2 aptamers that are S-Protein specific and may be a specific therapeutic agent for COVID-19 therapy.
SARS-CoV-2 Aptamers Development